Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial

Affiliations

• ¹ Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
• ² Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
• ³ Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany.
• ⁴ German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Luebeck, Hamburg, Germany.
• ⁵ Institute of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Germany.
• ⁶ Cardiology Unit, Camposampiero Hospital-AULSS Euganea, Italy.
• ⁷ Department of Medical Science, Uppsala University, Uppsala, Sweden.
• ⁸ Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
• ⁹ Department of Cardiology, Department of Regional Health Research, Esbjerg Hospital-University Hospital of Southern Denmark, University of Southern Denmark, Esbjerg, Denmark.
• ¹⁰ Atrial Fibrillation NETwork (AFNET), Muenster, Germany.
• ¹¹ Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, University of Birmingham, Edgbaston, Birmingham, UK.
• ¹² NIHR Birmingham Biomedical Research Centre and NIHR Applied Research Collaboration West Midlands, University of Birmingham, Edgbaston, Birmingham, UK.
• ¹³ Cardiovascular and Genetics Research Institute, St George's, University of London, London, UK.
• ¹⁴ Biostatistics Lab, School of Medicine, University of Crete, Crete, Greece.
• ¹⁵ Medicine University 'Carol Davila', Colentina University Hospital, Bucharest, Romania.
• ¹⁶ Department of Internal Medicine III, Cardiology and Angiology, Innsbruck Medical University, Innsbruck, Austria.
• ¹⁷ Department of Neuroepidemiology, Institute for Medical Informatics, Biometry and Epidemiology (IMIBE), University Duisburg-Essen, Essen, Germany.
• ¹⁸ Department of Cardiology and Intensive Care Medicine, St Vincenz-Hospital Paderborn, Paderborn, Germany.
• ¹⁹ Otto-von-Guericke Universität Magdeburg, Magdeburg, Germany.
• ²⁰ The Heart Center, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
• ²¹ Departments of Cardiology and Physiology, Maastricht University, Maastricht, The Netherlands.
• ²² Department of Cardiology and Internal Diseases, Medical University of Gdańsk, Gdańsk, Poland.
• ²³ Cardiology Division, European Georges Pompidou Hospital, Paris, France.
• ²⁴ Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.
• ²⁵ Department of Cardiology, Hospital Clinic, Universtitat de Barcelona, Catalonia, Spain.
• ²⁶ Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
• ²⁷ Centro de Investigacion Biomedica en Red Cardiovascular (CIBERCV), Madrid, Spain.
• ²⁸ Cardiac Department, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
• ²⁹ Department of Cardiology, University Hospital Antwerp, Edegem, Belgium.
• ³⁰ Division of Cardiology, Medical University of Graz, Austria.
• ³¹ Department of Cardiology, Heraklion University Hospital, Heraklion, Crete, Greece.
• ³² Biomedical Research Foundation Academy of Athens (BRFAA), Greece and Hygeia Hospitals Group, Athens, Greece.
• ³³ Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czechia.